Sangamo Therapeutics Inc (NASDAQ:SGMO) price on Thursday, December 26, rose 5.20% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $2.63.
A look at the stock’s price movement, the close in the last trading session was $2.50, moving within a range at $2.43 and $2.67. Turning to its 52-week performance, $3.18 and $0.30 were the 52-week high and 52-week low respectively. Overall, SGMO moved 35.57% over the past month.
Sangamo Therapeutics Inc’s market cap currently stands at around $548.74 million, with investors looking forward to this quarter’s earnings report slated for in January.
The average forecast suggests up to a 333.05% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 59.15M, representing a -66.44% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that SGMO is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 2 analyst(s) rate the stock as a Hold, 1 recommend SGMO as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Hold which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
SGMO’s current price about 17.01% and 29.05% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 60.88, while 7-day volatility ratio is 13.61% and 13.30% in the 30-day chart. Further, Sangamo Therapeutics Inc (SGMO) has a beta value of 1.17, and an average true range (ATR) of 0.29. Analysts have given the company’s stock an average 52-week price target of $12, forecast between a low of $5 and high of $19. Looking at the price targets, the low is -90.11% off current price level while to achieve the yearly target high, price needs to move -622.43%. Nonetheless, investors will most likely welcome a -356.27% jump to $12 which is the analysts’ median price.
If we refocus on Sangamo Therapeutics Inc (NASDAQ:SGMO), historical trading data shows that trading volumes averaged 9.6 over the past 10 days and 8.34 million over the past 3 months. The company’s latest data on shares outstanding shows there are 208.62 million shares.
The 4.54% of Sangamo Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 27.00% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 14.95 million on 2024-11-29, giving us a short ratio of 1.7. The data shows that as of 2024-11-29 short interest in Sangamo Therapeutics Inc (SGMO) stood at 721.0 of shares outstanding, with shares short falling to 18.98 million registered in 2024-10-31. Current price change has pushed the stock 384.08% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the SGMO stock continues to rise going into the next quarter.
